Empagliflozin reduces brain pathology in Alzheimer's disease and type 2 diabetes

Neural Regen Res. 2024 Jun 1;19(6):1189-1190. doi: 10.4103/1673-5374.385865. Epub 2023 Sep 22.
No abstract available